PE20000127A1 - Derivado de bencenosulfonamida - Google Patents
Derivado de bencenosulfonamidaInfo
- Publication number
- PE20000127A1 PE20000127A1 PE1998001240A PE00124098A PE20000127A1 PE 20000127 A1 PE20000127 A1 PE 20000127A1 PE 1998001240 A PE1998001240 A PE 1998001240A PE 00124098 A PE00124098 A PE 00124098A PE 20000127 A1 PE20000127 A1 PE 20000127A1
- Authority
- PE
- Peru
- Prior art keywords
- alcoxy
- alkyl
- substituted
- carbamoyl
- carbonyl
- Prior art date
Links
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 2
- KKFDJZZADQONDE-UHFFFAOYSA-N (hydridonitrato)hydroxidocarbon(.) Chemical class O[C]=N KKFDJZZADQONDE-UHFFFAOYSA-N 0.000 abstract 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical class [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 102000028517 Neuropeptide receptor Human genes 0.000 abstract 1
- 108070000018 Neuropeptide receptor Proteins 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical class O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19757248 | 1997-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000127A1 true PE20000127A1 (es) | 2000-03-14 |
Family
ID=7853006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998001240A PE20000127A1 (es) | 1997-12-22 | 1998-12-17 | Derivado de bencenosulfonamida |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR014406A1 (fr) |
| AU (1) | AU2415299A (fr) |
| CO (1) | CO5011105A1 (fr) |
| PE (1) | PE20000127A1 (fr) |
| WO (1) | WO1999032466A1 (fr) |
| ZA (1) | ZA9811705B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2350714A1 (fr) | 1998-11-10 | 2000-05-18 | Merck & Co., Inc. | Spiro-indolines en tant qu'antagonistes du recepteur y5 |
| FR2792314B1 (fr) * | 1999-04-15 | 2001-06-01 | Adir | Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6218408B1 (en) | 1999-06-30 | 2001-04-17 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
| US6340683B1 (en) | 1999-04-22 | 2002-01-22 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (triazines) |
| US6989379B1 (en) | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
| EP1183245B1 (fr) * | 1999-04-22 | 2007-05-09 | H. Lundbeck A/S | Antagonistes selectifs npy (y5) |
| US6225330B1 (en) | 1999-06-30 | 2001-05-01 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
| US6214853B1 (en) | 1999-06-30 | 2001-04-10 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
| US6222040B1 (en) | 1999-06-30 | 2001-04-24 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
| US7273880B2 (en) | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
| DK1249233T3 (da) * | 1999-11-26 | 2008-11-17 | Shionogi & Co | NPYY5-antagonister |
| JP2003525291A (ja) * | 2000-03-01 | 2003-08-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ２，４−二置換チアゾリル誘導体 |
| FR2815346B1 (fr) * | 2000-10-13 | 2004-02-20 | Servier Lab | Nouveaux composes aminotriazolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2002078697A1 (fr) * | 2001-03-29 | 2002-10-10 | Smithkline Beecham Corporation | Composes et procedes |
| CA2403307A1 (fr) | 2001-10-23 | 2003-04-23 | Neurogen Corporation | Derives de l'imidazole 2-cyclohexyl-4-phenyl-1h substitue |
| TW200303742A (en) * | 2001-11-21 | 2003-09-16 | Novartis Ag | Organic compounds |
| BRPI0409447A (pt) * | 2003-04-14 | 2006-04-18 | Inst For Pharm Discovery Inc | ácidos fenilalcanóicos substituìdos |
| EA200501710A1 (ru) | 2003-04-30 | 2006-06-30 | ДЗЕ ИНСТИТЬЮТС ФОР ФАРМАСЬЮТИКАЛ ДИСКАВЕРИ, ЭлЭлСи | Замещённые карбоновые кислоты |
| WO2006042215A1 (fr) | 2004-10-08 | 2006-04-20 | Janssen Pharmaceutica, N.V. | Derives de 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide |
| GB0526257D0 (en) | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
| US9353078B2 (en) * | 2013-10-01 | 2016-05-31 | New York University | Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof |
| EP4077290A1 (fr) | 2019-12-20 | 2022-10-26 | Ikena Oncology, Inc. | Dérivés de 4-phényl-n-(phényl)thiazol-2-amine et composés associés utilisés comme agonistes du récepteur d'hydrocarbure aryle (ahr) pour le traitement, par ex., de trouble liés à l'angiogenèse ou inflammatoires |
| WO2025017207A1 (fr) * | 2023-07-20 | 2025-01-23 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Inhibiteurs de smndc1 et leur utilisation thérapeutique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3776765A (en) * | 1972-02-28 | 1973-12-04 | Cities Service Co | Process for protecting a substrate with an n{11 substituted aminoarylsulfonamide intumescent agent |
| FR2701480B1 (fr) * | 1993-02-15 | 1995-05-24 | Sanofi Elf | Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
| AU3201095A (en) * | 1994-07-27 | 1996-02-22 | G.D. Searle & Co. | Substituted thiazoles for the treatment of inflammation |
-
1998
- 1998-12-17 CO CO98075202A patent/CO5011105A1/es unknown
- 1998-12-17 PE PE1998001240A patent/PE20000127A1/es not_active Application Discontinuation
- 1998-12-18 AR ARP980106523A patent/AR014406A1/es unknown
- 1998-12-18 WO PCT/EP1998/008333 patent/WO1999032466A1/fr not_active Ceased
- 1998-12-18 AU AU24152/99A patent/AU2415299A/en not_active Abandoned
- 1998-12-21 ZA ZA9811705A patent/ZA9811705B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9811705B (en) | 1999-09-07 |
| AU2415299A (en) | 1999-07-12 |
| CO5011105A1 (es) | 2001-02-28 |
| WO1999032466A1 (fr) | 1999-07-01 |
| AR014406A1 (es) | 2001-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000127A1 (es) | Derivado de bencenosulfonamida | |
| ES2161231T3 (es) | Compuestos heterociclicos como antagonistas de bradiquinina. | |
| MX9300842A (es) | Antagonistas de endotelina de sulfonamida. | |
| ES2135414T3 (es) | Antagonistas del receptor 5-ht4. | |
| ES2031513T3 (es) | Quinazolindionas y piridopirimidinadionas. | |
| DK0640592T3 (da) | N-acylerede tricycliske azaheteroringe anvendelige som vasopressin-antagonister | |
| ES2122504T3 (es) | Ciertas pirrol-carboxanilidas condensadas; una nueva clase de ligandos del receptor cerebral de gaba. | |
| ES2144412T3 (es) | Derivados de bencimidazoles como antagonistas de 5-ht1a y 5ht2. | |
| PE20040935A1 (es) | Analogos de 2-quinazolina sustituida-4-ilamina como moduladores de los receptores de capsaicina | |
| FI943247A0 (fi) | Piperatsiinijohdannaisia 5-HT-reseptoriantagonisteina | |
| CO5031253A1 (es) | Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen | |
| ES2138977T3 (es) | Agonistas muscarinicos. | |
| PE34096A1 (es) | Derivado triciclico del pirazol | |
| ES2151601T3 (es) | 4-aril-1-(indanmetil, dihidrobenzofuranmetil o dihidrobenzotiofenometil)-piperidinas, -tetrahidropiridinas o -piperazinas. | |
| AR039489A1 (es) | Derivados de tetrahidropiranil ciclopentil tetrahidropiridopiridina, moduladores de actividad de receptores de citoquinas | |
| PE91798A1 (es) | Pirrolicarboxanilidas condensadas: utiles como ligandos receptores | |
| ATE362371T1 (de) | Somatostatin-analoge mit einer zyklisierten konformationsbeschränkten hauptkette | |
| ES2188890T3 (es) | Derivados del acido quinoleincarboxilico y sus sales. | |
| ES2177767T3 (es) | Analogos de suksdorfina, composiciones de los mismos y metodos para elaborar y usar los mismos. | |
| DE69903333D1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
| TR200000025T2 (tr) | Azetidinilpropilpiperidin türevleri, ara bağlarıyla tacikinin antagonistleri olarak kullanımları. | |
| ES2158840T3 (es) | Nuevos analogos de adenosina carbociclicos utiles como inmunosupresores. | |
| AR029400A1 (es) | Derivados de isoxazolcarboxamida, un metodo para su preparacion y una composicion farmaceutica que los comprende | |
| ES2191180T3 (es) | Antagonistas de los receptores de la dopamina benzoxazinona d4. | |
| MX9604368A (es) | Antagonistas de receptores de endotelina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |